New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling

New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling

Giant-cell tumor of bone (GCTB) is an intermediate type of primary bone tumor characterized by locally aggressive growth with metastatic potential. The aim of this study was to identify new druggable targets among the cell signaling molecules involved in GCTB tumorigenesis. Profiles of activated sig...

Full description

Bibliographic Details
Main Authors: Michal Mahdal, Jakub Neradil, Peter Mudry, Silvia Paukovcekova, Iva Staniczkova Zambo, Jiri Urban, Peter Macsek, Lukas Pazourek, Tomas Tomas, Renata Veselska
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
giant-cell tumor of bone
targeted treatment
sunitinib
PDGFR beta
denosumab
signaling
Online Access:https://www.mdpi.com/2072-6694/13/14/3543

Internet

https://www.mdpi.com/2072-6694/13/14/3543

Similar Items